Company profile for NanoNewron

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ChatGPT said: NeuroNova is advancing treatments for degenerative CNS diseases by overcoming the Blood Brain Barrier (BBB) challenge. Using our proprietary NewroBus Technology—humanized camelid nanobodies that exploit TfR1-mediated transcytosis—we deliver biologics directly into the brain. Our lead focus is Alzheimer’s Disease, targeting TNF-α, a key driver of neurodegeneration. NN-841, our clinical candidate, links a...
ChatGPT said: NeuroNova is advancing treatments for degenerative CNS diseases by overcoming the Blood Brain Barrier (BBB) challenge. Using our proprietary NewroBus Technology—humanized camelid nanobodies that exploit TfR1-mediated transcytosis—we deliver biologics directly into the brain. Our lead focus is Alzheimer’s Disease, targeting TNF-α, a key driver of neurodegeneration. NN-841, our clinical candidate, links a NewroBus carrier to potent TNF-α inhibitors, achieving high brain penetration, strong TNF-α inhibition, and excellent tolerability, offering a promising approach to treat AD and related disorders.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Townsend Hall T217 1000 Morris Avenue Union, NJ 07083
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty